Lecia V. Sequist, discusses the adverse event profiles of rociletinib (CO-1686) and osimertinib (AZD9291).
Lecia V. Sequist
Advertisement
Articles by Lecia V. Sequist
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.
Advertisement
Latest Updated Articles
Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLCPublished: September 24th 2015 | Updated:
Lecia V. Sequist on Side Effects From Agents for Resistant Lung CancerPublished: September 25th 2015 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Living With Leukemia Chester Freeman Embraces Wabi-Sabi
2
Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’
3
Becoming Cancer-Aware: How My Diagnosis Changed the Way My Family Sees Everyday Products
4
What Are My Options for Liver Cancer Treatment?
5
